Alecensaro (alectinib)

pCPA File Number: 21039

Negotiation Status:

Concluded with an LOI

Indication(s):

Non-small cell lung cancer (NSCLC), locally advanced or metastatic

Sponsor/Manufacturer:

Hoffmann-La Roche Ltd.

CDA-AMC Project Number:

PC0114-000

pCPA Engagement Letter Issued:

2018-09-07

Negotiation Process Concluded:

2018-12-11